Note: This document contains side effect information about cabazitaxel. Some dosage forms listed on this page may not apply to the brand name Jevtana.
Summary
Common side effects of Jevtana include: neutropenia, diarrhea, nausea, and vomiting. Other side effects include: febrile neutropenia, hypotension, and dehydration. Continue reading for a comprehensive list of adverse effects.
Applies to cabazitaxel: intravenous solution.
Warning
Intravenous route (Solution)
NeutropeniaNeutropenic deaths have been reported. Monitor for neutropenia with frequent blood cell counts. Cabazitaxel is contraindicated in patients with neutrophil counts of less than or equal to 1500 cells/mm(3). Primary prophylaxis with G-CSF is recommended in patients with high-risk clinical features. Consider primary prophylaxis with G-CSF in all patients receiving a dose of 25 mg/m(2).Severe HypersensitivitySevere hypersensitivity reactions can occur and may include generalized rash/erythema, hypotension and bronchospasm. Severe hypersensitivity reactions require immediate discontinuation of the cabazitaxel infusion and administration of appropriate therapy. Patients should receive premedication. Cabazitaxel is contraindicated in patients who have a history of severe hypersensitivity reactions to cabazitaxel or to drugs formulated with polysorbate 80.
Serious side effects of Jevtana
Along with its needed effects, cabazitaxel (the active ingredient contained in Jevtana) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking cabazitaxel:
More common
- Black, tarry stools
- bleeding gums
- bloating or swelling of the face, arms, hands, lower legs, or feet
- blood in the urine or stools
- burning, numbness, tingling, or painful sensations
- chest pain
- chills
- cough
- difficult or labored breathing
- difficult or painful urination
- fever
- lower back or side pain
- pale skin
- pinpoint red spots on the skin
- rapid weight gain
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- swollen glands
- tightness in the chest
- unsteadiness or awkwardness
- unusual bleeding or bruising
- unusual tiredness or weakness
- unusual weight gain or loss
- weakness in the arms, hands, legs, or feet
Less common
- Blurred vision
- confusion
- decreased urination
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- dry mouth
- fainting
- fast, slow, or irregular heartbeat
- lightheadedness
- rapid breathing
- sunken eyes
- sweating
- thirst
- wrinkled skin
Incidence not known
- Blue lips, fingernails, or skin
- burning feeling in the chest or stomach
- fast breathing
- frequent urination
- general feeling of discomfort or illness
- indigestion
- lower abdominal cramping
- nausea
- severe constipation
- stomach pain or upset
- tenderness in the stomach area
- thickening of bronchial secretions
- vomiting
Other side effects of Jevtana
Some side effects of cabazitaxel may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Belching
- change in taste
- constipation
- cracked lips
- decreased weight
- diarrhea
- difficulty with swallowing
- hair loss
- headache
- heartburn
- indigestion
- lack or loss of strength
- loss of appetite
- stomach discomfort
- thinning of the hair
- weight loss
Less common
- Back pain
- difficulty with moving
- muscle pain, spasm, or stiffness
- pain in the joints
- pain, itching, burning, swelling, or a lump under your skin where the needle is placed
For Healthcare Professionals
Applies to cabazitaxel: intravenous solution.
General
The most common adverse events were anemia, leukopenia, neutropenia, thrombocytopenia, and diarrhea.[Ref]
Hematologic
Very common (10% or more): Anemia (98%), leukopenia (96%), neutropenia (94%), thrombocytopenia (48%)
Common (1% to 10%): Febrile neutropenia[Ref]
Gastrointestinal
Very common (10% or more): Diarrhea (47%), nausea (34%), vomiting (22%), constipation (20%), abdominal pain (17%), dyspepsia (10%)
Common (1% to 10%): Abdominal pain upper, hemorrhoids, gastroesophageal reflux disease, rectal hemorrhage, dry mouth, abdominal distension
Frequency not reported: Death related to diarrhea and electrolyte imbalance, GI hemorrhage and perforation, ileus, enterocolitis, neutropenic enterocolitis, colitis
Postmarketing reports: Gastritis, intestinal obstruction[Ref]
Nervous system
Very common (10% or more): Fatigue (37%), dysgeusia (11%)
Common (1% to 10%): Dizziness, peripheral neuropathy, headache, peripheral sensory neuropathy, paresthesia, lethargy, hypoesthesia, tinnitus, vertigo, sciatica
Frequency not reported: Peripheral motor neuropathy, fatal cerebral hemorrhage[Ref]
Other
Very common (10% or more): Asthenia (20%), pyrexia (12%)
Common (1% to 10%): Mucosal inflammation, pain, death due to causes other than disease progression, malaise[Ref]
Respiratory
Very common (10% or more): Dyspnea (12%), cough (11%)
Common (1% to 10%): Oropharyngeal pain[Ref]
Cardiovascular
Common (1% to 10%): Peripheral edema, arrhythmia, hypotension, deep vein thrombosis, hypertension, tachycardia, grade 3 or higher arrhythmias, orthostatic hypotension, hot flush, flushing, atrial fibrillation
Uncommon (0.1% to 1%): Cardiac failure, cardiac arrest, fatal ventricular fibrillation[Ref]
Renal
Uncommon (0.1% to 1%): Grade 3 to 4 increased AST, grade 3 to 4 increased ALT, increased bilirubin
Frequency not reported: Fatal renal failure[Ref]
Metabolic
Very common (10% or more): Anorexia (16%)
Common (1% to 10%): Weight decreased, dehydration, edema, hyperglycemia, hypokalemia[Ref]
Genitourinary
Very common (10% or more): Hematuria (17%)
Common (1% to 10%): Dysuria, pollakiuria, urinary retention, urinary incontinence, ureteric obstruction, pelvic pain[Ref]
Hepatic
Common (1% to 10%): AST increased, transaminases increased
Uncommon (0.1% to 1%): ALT increased, bilirubin increased[Ref]
Hypersensitivity
Common (1% to 10%): Hypersensitivity[Ref]
Musculoskeletal
Very common (10% or more): Back pain (16%), arthralgia (10.5%)
Common (1% to 10%): Pain in extremity, muscle spasms, myalgia, musculoskeletal chest pain, flank pain, chills[Ref]
Immunologic
Common (1% to 10%): Urinary tract infection, influenza, cystitis, upper respiratory tract infection, pneumonia, cellulitis, herpes zoster, septic shock, sepsis, candidiasis
Uncommon (0.1% to 1%): Neutropenic sepsis, neutropenic infections
Frequency not reported: Fatal infection[Ref]
Dermatologic
Very common (10% or more): Alopecia (10%)
Common (1% to 10%): Dry skin, erythema[Ref]
Ocular
Common (1% to 10%): Conjunctivitis, increased lacrimation[Ref]
Psychiatric
Common (1% to 10%): Anxiety, confusional state[Ref]